Cargando…

Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel

Molnupiravir (MOV) was introduced in Israel in January 2022 during the SARS-CoV-2 Omicron surge for high-risk patients contraindicated for nirmatrelvir/ritonavir. This retrospective cohort study aimed to describe characteristics of patients offered COVID-19 antiviral treatment in Maccabi Healthcare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weil, Clara, Bergroth, Tobias, Eisenberg, Anna, Whiteside, Yohance Omar, Caraco, Yoseph, Tene, Lilac, Chodick, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443270/ https://www.ncbi.nlm.nih.gov/pubmed/37606468 http://dx.doi.org/10.3390/epidemiologia4030031

Ejemplares similares

79. Long-term Health Outcomes of Individuals who are Infected with SARS-CoV-2 and Develop COVID-19
por: Tene, Lilac, et al.
Publicado: (2022)

Real-World Evidence for Equality
por: Johnson, C. Erwin, et al.
Publicado: (2021)

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel
por: Yekutiel, Naama, et al.
Publicado: (2023)

Characteristics of Atopic Dermatitis Patients Treated with Crisaborole: Real-World Data from a Large Healthcare Provider Database in Israel
por: Weil, Clara, et al.
Publicado: (2022)

Burden of Endometriosis: Infertility, Comorbidities, and Healthcare Resource Utilization
por: Eisenberg, Vered H., et al.
Publicado: (2022)

Cutaneous Comorbidities Associated With Atopic Dermatitis in Israel: A Retrospective Real-World Data Analysis
por: Leshem, Yael A., et al.
Publicado: (2022)

Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
por: Flisiak, Robert, et al.
Publicado: (2022)

Correction: Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
por: Flisiak, Robert, et al.
Publicado: (2022)

Iron deficiency and the effectiveness of the BNT162b2 vaccine for SARS-CoV-2 infection: A retrospective, longitudinal analysis of real-world data
por: Tene, Lilac, et al.
Publicado: (2023)

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
por: Jayk Bernal, Angélica, et al.
Publicado: (2021)

Healthcare utilization, costs, and epidemiology of Huntington’s disease in Israel
por: Barer, Yael, et al.
Publicado: (2023)

Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir
por: Liu, Yayun, et al.
Publicado: (2022)

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic
por: Suzuki, Yasuhito, et al.
Publicado: (2022)

Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization
por: Chodick, Gabriel, et al.
Publicado: (2021)

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
por: Li, Pengfei, et al.
Publicado: (2022)

Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model
por: Rosenke, Kyle, et al.
Publicado: (2022)

1560. Factors Driving Decisions in the use of HIV Pre-Exposure Prophylaxis: Data from a Real-World Study in the United States
por: Whiteside, Yohance, et al.
Publicado: (2023)

The Clinical and Economic Burden of Tardive Dyskinesia in Israel: Real-World Data Analysis
por: Barer, Yael, et al.
Publicado: (2022)

Association of Molnupiravir and Nirmatrelvir-Ritonavir with reduced mortality and sepsis in hospitalized omicron patients: a territory-wide study
por: Wai, Abraham Ka-chung, et al.
Publicado: (2023)

Antiviral Efficacy and Safety of Molnupiravir Against Omicron Variant Infection: A Randomized Controlled Clinical Trial
por: Zou, Rongrong, et al.
Publicado: (2022)

Real-World Clinical Outcomes of Molnupiravir for the Treatment of Mild to Moderate COVID-19 in Adult Patients during the Dominance of the Omicron Variant: A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2023)

Echocardiographic Findings in Patients With COVID-19 With Myocardial Injury During the Omicron Variant Surge
por: Alam, Loba, et al.
Publicado: (2022)

Impact of Omicron surge in community setting in greater Paris area
por: Dinh, Aurélien, et al.
Publicado: (2022)

Croup during the Coronavirus Disease 2019 Omicron Variant Surge
por: Tunҫ, Emine M., et al.
Publicado: (2022)

Impact of Omicron surge in community setting in greater Paris area
por: Dinh, A., et al.
Publicado: (2022)

Molnupiravir: First Approval
por: Syed, Yahiya Y.
Publicado: (2022)

Computational Analysis of Molnupiravir
por: Sharov, Artem V., et al.
Publicado: (2022)

Molnupiravir for COVID-19
Publicado: (2022)

Epidemiology of Progressive Supranuclear Palsy: Real World Data from the Second Largest Health Plan in Israel
por: Barer, Yael, et al.
Publicado: (2022)

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
por: Vangeel, Laura, et al.
Publicado: (2022)

829. Identification of Congenital Cytomegalovirus Infection Using Real-World Healthcare Data
por: Weil, Clara, et al.
Publicado: (2020)

Right Ventricular Abnormality in Patients Hospitalized With COVID-19 Infection During Omicron Variant Surge
por: Salem Omar, Alaa Mabrouk, et al.
Publicado: (2022)

Hemato-oncology Tourism in Israel: A Retrospective Review
por: Hod, Keren, et al.
Publicado: (2020)

COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge
por: Bronstein, Yotam, et al.
Publicado: (2022)

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
por: Arbel, Ronen, et al.
Publicado: (2022)

The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real‐world data in Israel
por: Melzer Cohen, Cheli, et al.
Publicado: (2020)

Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial
por: Liu, Yayun, et al.
Publicado: (2023)

Real-World Treatment Patterns and Outcomes of Growth Hormone Treatment Among Children in Israel Over the Past Decade (2004–2015)
por: Ben-Ari, Tal, et al.
Publicado: (2021)

SAT-281 Relationship between Socioeconomic Status, Adherence and Outcomes to Growth Hormone Treatment in Children: Real-World Treatment Patterns in Israel
por: Ben-Ari, Tal, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_64qav3l73u9vrmlc6t6fhdojah